Xerri L - Search Results

1

CXCR5 and ICOS expression identifies a CD8 T-cell subset with T_FH features in Hodgkin lymphomas.

Le KS, Amé-Thomas P, Tarte K, Gondois-Rey F, Granjeaud S, Orlanducci F, Foucher ED, Broussais F, Bouabdallah R, Fest T, Leroux D, Yadavilli S, Mayes PA, Xerri L, Olive D. Le KS, et al. Among authors: xerri l. Blood Adv. 2018 Aug 14;2(15):1889-1900. doi: 10.1182/bloodadvances.2018017244. Blood Adv. 2018. PMID: 30087107 Free PMC article.

2

In situ expression of the IL-1-alpha and TNF-alpha genes by Reed-Sternberg cells in Hodgkin's disease.

Xerri L, Birg F, Guigou V, Bouabdallah R, Poizot-Martin I, Hassoun J. Xerri L, et al. Int J Cancer. 1992 Mar 12;50(5):689-93. doi: 10.1002/ijc.2910500504. Int J Cancer. 1992. PMID: 1312061

3

PCR-mismatch analysis of p53 gene mutation in Hodgkin's disease.

Xerri L, Parc P, Bouabdallah R, Camerlo J, Hassoun J. Xerri L, et al. J Pathol. 1995 Feb;175(2):189-94. doi: 10.1002/path.1711750206. J Pathol. 1995. PMID: 7738714

4

Expression of the p53 gene in Hodgkin's disease: dissociation between immunohistochemistry and clinicopathological data.

Xerri L, Bouabdallah R, Camerlo J, Hassoun J. Xerri L, et al. Hum Pathol. 1994 May;25(5):449-54. doi: 10.1016/0046-8177(94)90116-3. Hum Pathol. 1994. PMID: 8200638

5

Heterogeneity of rearranged T-cell receptor V-alpha and V-beta transcripts in tumor-infiltrating lymphocytes from Hodgkin's disease and non-Hodgkin's lymphoma.

Xerri L, Mathoulin MP, Birg F, Bouabdallah R, Stoppa AM, Hassoun J. Xerri L, et al. Am J Clin Pathol. 1994 Jan;101(1):76-80. doi: 10.1093/ajcp/101.1.76. Am J Clin Pathol. 1994. PMID: 8279454

6

Frequent expression of FAS/APO-1 in Hodgkin's disease and anaplastic large cell lymphomas.

Xerri L, Carbuccia N, Parc P, Hassoun J, Birg F. Xerri L, et al. Histopathology. 1995 Sep;27(3):235-41. doi: 10.1111/j.1365-2559.1995.tb00215.x. Histopathology. 1995. PMID: 8522287

7

In vivo expression of the CTLA4 inhibitory receptor in malignant and reactive cells from human lymphomas.

Xerri L, Devilard E, Hassoun J, Olive D, Birg F. Xerri L, et al. J Pathol. 1997 Oct;183(2):182-7. doi: 10.1002/(SICI)1096-9896(199710)183:2<182::AID-PATH918>3.0.CO;2-I. J Pathol. 1997. PMID: 9390031

8

Sensitivity to Fas-mediated apoptosis is null or weak in B-cell non-Hodgkin's lymphomas and is moderately increased by CD40 ligation.

Xerri L, Bouabdallah R, Devilard E, Hassoun J, Stoppa AM, Birg F. Xerri L, et al. Br J Cancer. 1998 Jul;78(2):225-32. doi: 10.1038/bjc.1998.469. Br J Cancer. 1998. PMID: 9683298 Free PMC article.

9

Analysis of BAX expression in human tissues using the anti-BAX, 4F11 monoclonal antibody on paraffin sections.

Penault-Llorca F, Bouabdallah R, Devilard E, Charton-Bain MC, Hassoun J, Birg F, Xerri L. Penault-Llorca F, et al. Among authors: xerri l. Pathol Res Pract. 1998;194(7):457-64. doi: 10.1016/s0344-0338(98)80114-3. Pathol Res Pract. 1998. PMID: 9728362

10

FADD expression and caspase activation in B-cell lymphomas resistant to Fas-mediated apoptosis.

Xerri L, Devilard E, Bouabdallah R, Stoppa AM, Hassoun J, Birg F. Xerri L, et al. Br J Haematol. 1999 Sep;106(3):652-61. doi: 10.1046/j.1365-2141.1999.01586.x. Br J Haematol. 1999. PMID: 10468853 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

248 results

Search Page

Filters